C

Cheiron

HealthAI-Native Drug DevelopmentB2B📍 Los Altos, United States

Cheiron is an AI biotech startup that has developed a generative AI platform for drug development. It targets the biopharma market by providing a comprehensive operating system that integrates various data sources to support drug developers. The recent funding will help expand its capabilities and enhance its Life Sciences Knowledge Graph.

Total raised
$8M
tracked to date
Latest round
Seed
Jul 23, 2026
Known investors
6
led by Menlo Ventures

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 USA Funding Report

Read the Q3 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 USA Funding Report</a>

Funding history

  1. 1
    $8MSeedJul 23, 2026

    Led by Menlo Ventures

    Announcement ↗

Investors in Cheiron

Backers from this company's tracked funding rounds.

Cheiron in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile